Clinical Trial Update: Kinetic Biomarker for Chronic Lymphocytic Leukemia Prognosis

View source ↗

Summary

KineMed reports the completion of a trial evaluating a kinetic biomarker for prognosis in chronic lymphocytic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Snippet

Sponsor: KineMed | Conditions: Chronic Lymphocytic Leukemia | Status: COMPLETED